Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00406289
Other study ID # 2006/391
Secondary ID
Status Completed
Phase Phase 1
First received November 30, 2006
Last updated September 3, 2010
Start date November 2006
Est. completion date February 2010

Study information

Verified date September 2010
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study will evaluate the feasibility of higher and prolonged dose escalation concentrated in the intra-tumoral regions which are FDG-avid after two weeks of radiotherapy.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date February 2010
Est. primary completion date August 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Head and neck tumor

- Aged > 18 years

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
18F-FDG-PET radiotherapy


Locations

Country Name City State
Belgium University Hospital Ghent Ghent

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tumor recurrences
See also
  Status Clinical Trial Phase
Completed NCT06016335 - MRI-based Synthetic CT Images of the Head and Neck N/A
Recruiting NCT05053230 - A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer N/A
Completed NCT01228448 - In-Room PET in Proton Radiation Therapy N/A
Completed NCT04334239 - Effectiveness of Care in Certified Cancer Centres in Germany
Recruiting NCT05183243 - Dose Finding Study of GH21 in Adult Patients With Advanced Solid Tumors Phase 1
Recruiting NCT06438705 - 99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Recruiting NCT04075305 - The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study